bladder cancer
Qlucore Expands Into Bladder Cancer Diagnostics With Lund University Partnership
The company expects that this work to develop and validate classifier models for bladder cancer will lead to a CE mark for its Qlucore Diagnostics software platform.
Bio-Techne, Nonagen Bioscience Ink Agreement to Manufacture Multiplex Bladder Cancer Panel
Bio-Techne will manufacture Nonagen's Oncuria, a protein-based urine test for the early detection, therapy choice, and disease monitoring of bladder cancer.
Scienion envisions a 2024 worldwide market debut for the in vitro diagnostic and plans for it to be used at the point of care.
Scienion, IPA Partner to Develop Rapid Bladder Cancer Diagnostics Platform
The collaborators are developing a multiplexed, lateral-flow diagnostic test to detect 10 bladder cancer biomarkers from a urine sample at the point of care and in the lab.
Elypta Expands Trial for Liquid Biopsy Kidney Cancer Recurrence Test; Plans Bladder Cancer Assay
Premium
Elypta is also developing a third test for the early detection of multiple cancers, which the company believes could eventually be used for routine cancer screening.